Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-31

FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application to add a 25 mg strength of Losartan Potassium Tablets, expanding the product's dosage options. The approval was issued t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium Tablets, 25 mg (LOSARTAN POTASSIUM)

Snippet

SUPPL AP for LOSARTAN POTASSIUM TABLETS, 25 MG (LOSARTAN POTASSIUM)